文献速递神经免疫

多发性硬化患者的皮质神经元密度与脑白质脱髓鞘:一项回顾性研究

Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study.
PubMed 文献 · Lancet Neurol · 2018-08-22

该回顾性研究比较了12例髓皮质型多发性硬化与12例典型多发性硬化及对照脑的病理改变,发现髓皮质型无脑白质脱髓鞘但存在皮质神经元密度降低,提示皮质神经元丢失可独立于脑白质脱髓鞘发生。

要点

  • 髓皮质型多发性硬化表现为脊髓和大脑皮质脱髓鞘,但无脑白质脱髓鞘。
  • 髓皮质型多发性硬化皮质神经元密度较对照组显著降低。
  • 典型多发性硬化仅在第V层皮质神经元密度较对照组降低。

核心结论

  • 作者提出髓皮质型多发性硬化是多发性硬化的一个亚型,以脊髓和大脑皮质脱髓鞘但无脑白质脱髓鞘为特征。
  • 皮质神经元丢失不伴脑白质脱髓鞘,在髓皮质型多发性硬化中可为独立的病理事件。
  • 与对照脑相比,髓皮质型多发性硬化的皮质神经元丢失较典型多发性硬化更明显。
  • 髓皮质型多发性硬化中原发性神经元变性和轴突病理的分子机制应在未来研究中探讨。

研究设计与样本

  • 回顾性研究,遗体解剖取自美国俄亥俄州克利夫兰克利夫兰诊所死于多发性硬化的患者。
  • 1998年5月至2012年11月间采集100例患者的脑和脊髓,研究于2011年9月6日至2018年2月2日进行。
  • 识别出12例髓皮质型多发性硬化,按年龄、性别、MRI方案、多发性硬化疾病亚型、疾病病程和扩展残疾状况量表与12例典型多发性硬化匹配。
  • 用髓鞘蛋白免疫细胞化学比较两组脑白质、脊髓和大脑皮质组织切片的脱髓鞘病变面积。
  • 比较两组及年龄匹配的无神经疾病证据的对照脑在5个与脊髓无直接连接的皮质区域第III、V、VI层神经元密度。

主要发现

  • 髓皮质型多发性硬化患者脊髓和大脑皮质检出脱髓鞘病变,但脑白质未检出。
  • 皮质脱髓鞘病变面积在髓皮质型与典型多发性硬化间相似(中位数4.45%[IQR 2.54-10.81] vs 9.74%[1.35-19.50];p=0.5512)。
  • 脊髓脱髓鞘面积典型多发性硬化显著大于髓皮质型(中位数3.81%[IQR 1.72-7.42] vs 13.81%[6.51-29.01];p=0.0083)。
  • 髓皮质型多发性硬化较对照脑平均皮质神经元密度显著降低:第III层349.8个/mm²[SD 51.9] vs 419.0[43.6](p=0.0104);第V层355.6[46.5] vs 454.2[48.3](p=0.0006);第VI层366.6[50.9] vs 458.3[48.4](p=0.0049)。
  • 典型多发性硬化较对照脑第V层平均皮质神经元密度降低(392.5[59.0] vs 454.2[48.3];p=0.0182),第III和VI层未降低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Demyelination of cerebral white matter is thought to drive neuronal degeneration and permanent neurological disability in individuals with multiple sclerosis. Findings from brain MRI studies, however, support the possibility that demyelination and neuronal degeneration can occur independently. We aimed to establish whether post-mortem brains from patients with multiple sclerosis show pathological evidence of cortical neuronal loss that is independent of cerebral white-matter demyelination. METHODS: Brains and spinal cords were removed at autopsy from patients, who had died with multiple sclerosis, at the Cleveland Clinic in Cleveland, OH, USA. Visual examination of centimetre-thick slices of cerebral hemispheres was done to identify brains without areas of cerebral white-matter discoloration that were indicative of demyelinated lesions (referred to as myelocortical multiple sclerosis) and brains that had cerebral white-matter discolorations or demyelinated lesions (referred to as typical multiple sclerosis). These individuals with myelocortical multiple sclerosis were matched by age, sex, MRI protocol, multiple sclerosis disease subtype, disease duration, and Expanded Disability Status Scale, with individuals with typical multiple sclerosis. Demyelinated lesion area in tissue sections of cerebral white matter, spinal cord, and cerebral cortex from individuals classed as having myelocortical and typical multiple sclerosis were compared using myelin protein immunocytochemistry. Neuronal densities in cortical layers III, V, and VI from five cortical regions not directly connected to spinal cord (cingulate gyrus and inferior frontal cortex, superior temporal cortex, and superior insular cortex and inferior insular cortex) were also compared between the two groups and with aged-matched post-mortem brains from individuals without evidence of neurological disease. FINDINGS: Brains and spinal cords were collected from 100 deceased patients between May, 1998, and November, 2012, and this retrospective study was done between Sept 6, 2011, and Feb 2, 2018. 12 individuals were identified as having myelocortical multiple sclerosis and were compared with 12 individuals identified as having typical multiple sclerosis. Demyelinated lesions were detected in spinal cord and cerebral cortex, but not in cerebral white matter, of people with myelocortical multiple sclerosis. Cortical demyelinated lesion area was similar between myelocortical and typical multiple sclerosis (median 4·45% [IQR 2·54-10·81] in myelocortical vs 9·74% [1·35-19·50] in typical multiple sclerosis; p=0·5512). Spinal cord demyelinated area was significantly greater in typical than in myelocortical multiple sclerosis (median 3·81% [IQR 1·72-7·42] in myelocortical vs 13·81% [6·51-29·01] in typical multiple sclerosis; p=0·0083). Despite the lack of cerebral white-matter demyelination in myelocortical multiple sclerosis, mean cortical neuronal densities were significantly decreased compared with control brains (349·8 neurons per mm2 [SD 51·9] in myelocortical multiple sclerosis vs 419·0 [43·6] in controls in layer III [p=0·0104]; 355·6 [46·5] vs 454·2 [48·3] in layer V [p=0·0006]; 366·6 [50·9] vs 458·3 [48·4] in layer VI [p=0·0049]). By contrast, mean cortical neuronal densities were decreased in typical multiple sclerosis brains compared with those from controls in layer V (392·5 [59·0] vs 454·2 [48·3]; p=0·0182) but not layers III and VI. INTERPRETATION: We propose that myelocortical multiple sclerosis is a subtype of multiple sclerosis that is characterised by demyelination of spinal cord and cerebral cortex but not of cerebral white matter. Cortical neuronal loss is not accompanied by cerebral white-matter demyelination and can be an independent pathological event in myelocortical multiple sclerosis. Compared with control brains, cortical neuronal loss was greater in myelocortical multiple sclerosis cortex than in typical multiple sclerosis cortex. The molecular mechanisms of primary neuronal degeneration and axonal pathology in myelocortical multiple sclerosis should be investigated in future studies. FUNDING: US National Institutes of Health and National Multiple Sclerosis Society.

来源:Lancet Neurol,查看原文。版权归原作者所有。

引用

  1. Trapp BD, Vignos M, Dudman J, et al. Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study. Lancet Neurol. 2018. PMID: 30143361. doi:10.1016/S1474-4422(18)30245-X

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。